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Abstract The aim of our study was to access office
hysteroscopy results in postmenopausal patients with thick-
ened endometrium. A retrospective descriptive study was
carried out on 245 postmenopausal patients submitted to office
hysteroscopy after sonographic diagnosis of thickened endo-
metrium in 20 consecutive months.Womenwere evaluated for
age, hormonal therapy, hysteroscopic findings, procedure
duration, complications and associated pain, and histological
diagnosis. Patients with and without uterine bleeding were
considered separately. Symptomatic patients were older and
had longer procedure duration. The most frequent hystero-
scopic finding was endometrial polyp in both groups. Pain was
subjectively assessed in a numeric scale from 0 to 10 and
median value was 4. There were no complications reported.
Global neoplasia rate was 2.9% for asymptomatic patients and
16.4% for symptomatic ones (p<0.05). Thickened endome-
trium with postmenopausal metrorrhagia gave patients a
significantly higher risk for neoplasia and hyperplasia.
Keywords Office hysteroscopy . Endometrial neoplasms .
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Introduction
Endometrial cancer is known to be the most common
malignancy of the female genital tract in the developed
world. It occurs primarily after menopause and in most
cases presents with vaginal bleeding [1]. However, post-
menopausal vaginal bleeding is associated with endometrial
neoplasia in only about 10% to 30% of the cases [1–3].
Transvaginal ultrasound is the imaging procedure of choice
to evaluate patients with postmenopausal bleeding. The most
important sonographic sign of endometrial carcinoma is
thickened endometrium. In fact, with an endometrial thickness
of 5 mm or less, the chance of a patient having endometrial
cancer is about 1% [2, 4]. So transvaginal pelvic ultrasound
can be used as a screening tool for detection of endometrial
pathology in postmenopausal women.
The finding of an endometrial thickness greater than
4 mm, a polypoid endometrial mass, or a collection of fluid
within the uterus requires further evaluation, namely
endometrial biopsy. Hysteroscopy for thickened endometri-
um investigation after menopause is now widespread [5, 6].
The new generation of hysteroscopes combines miniatur-
ization with excellent image resolution and surgical ability.
The use of five French bipolar electrodes working in
normal saline solution, like the Versapoint® system
(Gynecare® Inc., USA), allows most of the pathology to
be safely diagnosed and operated at one outpatient session
[7, 8]. At present time, hysteroscopy can be done in an
office setting, providing information that cannot be
obtained by blind sampling and with high accuracy for
uterine cavity pathology diagnosis [5].
The aim of this study was to access office hysteroscopy
results in postmenopausal patients with sonographic thick-
ened endometrium and comparing the diagnostic outcomes
regarding presence or absence of abnormal bleeding.
Materials and methods
A retrospective analysis of all office hysteroscopies
performed in our institution for a period between January
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2005 and August 2006 was carried out (total=814). The
setting for these procedures was a gynecologic ambulatory
unit in a central hospital.
Women (n=245) included in the present study met the
following inclusion criteria: (1) menopausal for at least
1 year; (2) previous pelvic transvaginal ultrasound with
evidence of increased endometrial thickness; (3) primarily
proposed for office hysteroscopy to ascertain endometrial
cavity.
Two separate groups were then considered: group A
consisted of 172 patients with asymptomatic thickened
endometrium; and group B consisted of 73 patients with
increased endometrial thickness presenting with uterine
bleeding (symptomatic).
The ultrasonographic evaluations were performed at
several different centers by different operators; abdominal
and transvaginal 2D probes were always combined. Great-
est endometrium thickness was measured on a midline
sagittal uterus scan, including both anterior and posterior
endometrial layers and excluding the surrounding hypo-
echoic halo. The considered cut-off point was an endome-
trial thickness superior to 4 mm.
Patients were evaluated for several parameters: age,
hormonal therapy, pre-procedure preparation and anesthe-
sia, hysteroscopic findings and procedures, procedure
duration, associated pain and complications, and histopath-
ological diagnosis.
Diagnostic and operative hysteroscopies were performed
with a 5.5 mm rigid continuous flow hysteroscopic system,
with a five French working channel, connected to a 12° or
30° optics (Olympus®, Melville, USA). Uterine distension
was achieved with normal saline solution. The input
pressure was kept always below 100 mmHg. Operating
instruments utilized included scissors, graspers, and the
bipolar Versapoint system® (Gynecare Inc.), essentially the
Twizzle electrode® (Versapoint) for coagulating and cut-
ting. Simple biopsies were performed with graspers or
bipolar electrode under direct hysteroscopic guidance.
Polyps and fibroids resection was achieved with scissors
and mainly with bipolar device by cutting their pedicles. In
broad-based and bigger polyps and fibroids, first the
formation was cut into slices to easy resection and cervical
canal passage. All procedures were executed by the same
group of four surgeons.
Patients were admitted to the ambulatory unit and were
discharged between 15 min and 1 h after surgery, depend-
ing on their recovery. The pain was assessed by a visual
pain score list, graded from 0 to 10, which was registered
after each procedure.
Data were entered into an Excel 2002® (Microsoft Inc.)
database and statistical analysis was performed with SPSS
12.0® (Statistical package for social sciences, for Win-
dows). Continuous variables were evaluated with indepen-
dent samples t test and Mann–Whitney U test, and for
categorical variables we used the χ2 test, the Fisher exact
test, and the Kruskal–Wallis test (ordinal variables). We
considered statistical significance for a p value below 0.05.
Results
From the 245 hysteroscopic procedures evaluated, 204
(83.3%) were classified as operative and 41 (16.7%) as
diagnostic. The proportion of operative hysteroscopy was
identical in the two groups: 83.7% (144/172) in group A
and 82.2% (60/73) in group B.
Mean age of the study patients was 65.9±9.46 SD years,
minimum 46 and maximum 89. Table 1 presents population
characteristics distribution according to study groups. Mean
age was higher in women with symptomatic thickened
endometrium (67.9 years old) than in asymptomatic women
(64.9 years old) (p<0.05). The percentage of postmeno-
pausal women under hormonal replacement therapy (HRT)
was similar in the two groups, but tamoxifen users for
breast cancer chemoprophylaxis were significantly more
common among asymptomatic patients (13.4% versus
2.7%, p<0.05).
For procedure preparation, the majority (92.3%) of the
two groups’ women got vaginal misoprostol pre-operatively
(200 µg on the previous day) and one third also had a non-
steroid anti-inflammatory drug (400 mg of ibuprofen)
(Table 2). Local cervical anesthesia (5 cc of 1% lidocaine
without adrenaline) was administered in 3.5% of the
patients in group A and in 13.7% of those in group B (p>
0.05, non-significant).
Hysteroscopic findings are shown in Table 3. The most
frequent hysteroscopic diagnosis in both groups was
apparently benign endometrial polyp. In group A, benign
endometrial polyps occurred in 69.8% (120/172) of the
patients, 108 cases (62.8%) as isolated lesion, and 12 cases
Table 1 Population characteristics comparing asymptomatic (Group









64.9±9.3 SD 67.9±9.6 SD p=0.02** a
Patients under
hormonal therapy
19.8% 9.6% p>0.05* b
HRTc 6.4% 6.8% p>0.05* b
Tamoxifen therapy 13.4% 2.7% p=0.01** b
*p value non-significative, **p value significative
a t test
b Fisher exact test
c Hormonal replacement therapy
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(7%) in association with other benign findings. In group B,
65.7% (48/73) of the women had hysteroscopic diagnosis
of endometrial polyp, being 43 cases (58.9%) isolated and
five cases (6.8%) in association. Other benign lesions were
diagnosed in 15.7% (27/172) of asymptomatic patients and
in 9.6% (7/73) of symptomatic ones. The hysteroscopic
suspicion of endometrial carcinoma occurred more fre-
quently among symptomatic women, 17.8% (13/73) versus
2.9% (5/172) of the cases, respectively, for groups B and A
(p<0.05).
Table 4 presents the histopathology of obtained samples.
In 62.1% a benign endometrial polyp was the histological
diagnosis, with no significant difference between the two
study groups.
Regarding endometrial carcinoma, all the five suspected
cases in asymptomatic women were confirmed, and 11 of
the 13 suspected cases in symptomatic patients were
histologically confirmed. The two remaining cases were
endometrial hyperplasias (one simple hyperplasia and one
atypical complex hyperplasia). In group B, one case of
endometrial carcinoma was histologically diagnosed, with-
out previous hysteroscopic suspicion, which appeared on an
apparently benign polyp. So, in this study, hysteroscopy
showed sensitivity, specificity, positive predictive value,
and negative predictive value of 94.1%, 98.95%, 88.9%,
and 99.5 %, respectively, for endometrial carcinoma
diagnosis.
The histopathological diagnosis of endometrial hyper-
plasia was also more frequent among symptomatic patients,
however without statistical significance (group A, 3.5%
versus 8.2% in group B, p>0.05). The endometrial
hyperplasia diagnosis was suspected on hysteroscopy but
not confirmed in three cases. Two cases of hyperplasia
occurred in suspected carcinomas; one case appeared after
guided biopsy to apparent intrauterine adhesion area and
the remaining nine cases were diagnosed in apparently
benign polyps. All hyperplasias appeared among patients
that were not under tamoxifen therapy.
Overall, the concordance between hysteroscopic findings
and histological diagnosis was of 89.9% (187 cases in 208
applicable). See Table 5. From the apparently benign polyps
on hysteroscopy, 91% (151/166) were confirmed with
pathology. There was one case of polyp with focal
carcinoma (0.6%) among asymptomatic women and nine
cases of polyps with focal endometrial hyperplasia (5.4%)—
six in asymptomatic patients (two with atypical hyperplasia
and four with complex hyperplasia) and three in symptom-
atic patients (two with atypical hyperplasia and one simple
hyperplasia). Hysteroscopy had sensitivity, specificity, pos-
itive predictive value, and negative predictive value of
Total (n=245) Group A (n=172) Group B (n=73)
Misoprostol 58.8% 58.1% 60.3%
Misoprostol+NSAI 33.5% 37.3% 24.7%
NSAI 2.5% 1.7% 4.1%
Unknown 3.2% 2.9% 4.1%
None 2.0% – 6.8%
Table 2 Hysteroscopy prepara-
tion data among the two study
groups: asymptomatic (group A)
and symptomatic (group B)
patients
Table 3 Endoscopic diagnosis: comparison between group A (symptomatic) and group B (asymptomatic)
Group A (n=172) Group B (n=73) Statistical significance Total (n=245)
Normal uterine cavity 16 (9.3%) 3 (4.1%) p>0.05* a 7.8%
Benign isolated polyp 108 (62.8%) 43 (58.9%) p>0.05* b 61.65%
Other benign lesions
Fibroid 12 (7%) 2 (2.75%) p>0.05* a 5.7%
Intrauterine adhesion 9 (5.2%) 3 (4.1%) p>0.05* a 4.9%
Uterine septum 6 (3.4%) 2 (2.75%) p>0.05* a 3.3%
Endometrial carcinoma 5 (2.9%) 13 (17.8%) p=0.03** a 7.3%
Endometrial hyperplasia 2 (1.2%) 1 (1.4%) p>0.05* a 1.2%
Multiple benign findings
Benign polyp+other 12 (7%) 5 (6.8%) p>0.05* a 6.95%
Other 2 (1.2%) 1 (1.4%) p>0.05* a 1.2%
*p value non-significative, **p value significative
a Fisher exact test
bχ2 test
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98.7%, 72.7%, 91%, and 95.2%, respectively, for benign
polyp diagnosis.
No biopsy was performed in 27 cases of group A (12
normal cavity, two little polyps that were fulgurated, two
fibroids, seven intrauterine adhesions, and four uterine
septum) and four cases of group B (one normal cavity, two
intrauterine adhesions, and one uterine septum).
After hysteroscopic diagnosis of endometrial polyp, we
performed its complete excision in 91.1% of the cases (153/
168)—116/120 of asymptomatic (96.7%) and 45/48 in
symptomatic (93.8%). Partial polypectomy was performed
in 4.8% (eight), guided biopsy in 2.9% (five), and in 1.2%
(two) sample was not obtained because we fulgurated the
polyp. Versapoint® bipolar electrode was used in 92.8% of
operative hysteroscopies for polyps.
Myomectomy was performed 81.8% (18/22) of the cases
(14 isolated fibroids and eight associated). In the remaining
cases, intervention was not feasible or was not necessary.
The mean procedure duration was significantly longer in
group B with 36.1 min versus 31.5 min in group A (p<
0.05). Regarding pain subjective evaluation, the mean score
was 4 in both groups. See Table 6. There were no
complications related to procedure recorded in both groups.
Discussion
Transvaginal ultrasound is a valuable identification method
of women at risk for endometrial disease not only by
measuring the endometrium thickness but also by accessing
focal abnormalities within the endometrial cavity. Recent
meta-analysis [2, 9] concluded that the negative predictive
value of a thin endometrium (less than 5 mm) is very high
among women with postmenopausal bleeding. Hydro-
sonohysterography allows better visualization of focal
lesions within the cavity but is more painful than the
sonography alone and cannot reliably discriminate between
benign and malignant focal lesions [6].
The purpose of investigating postmenopausal women
with thickened endometrium is essentially to exclude
endometrial cancer, thus obtaining sample(s) for histopath-
ologic examination is fundamental and obligatory. Blind
endometrial biopsies (obtained with dilatation/curettage or
less invasive methods such as Vabra or Pipelle) were the
classical methods for obtaining endometrial samples. These
blind methods are associated with low-sensitivity diagnos-
tic rates for benign and malignant endometrial pathology [5,
6]. Nowadays, office hysteroscopy is considered the gold-
Histology
Carcinoma Hyperplasia Benign polyp Other benign No pathology
Endoscopy
Carcinoma 16 2 – – –
Hyperplasia – – 1 – 2
Benign polyp 1 9 151 3 2
Other benign – 1 1 13 1
No pathology – – – – 5
Table 5 Histological diagnosis
according to previous endosco-
py findings
Table 4 Histopathological diagnosis: comparison between group A (symptomatic) and group B (asymptomatic)
Group A (n=172) Group B (n=73) Statistical significance Total (n=245)
Normal endometrium 7 (4.1%) 5 (6.8%) p>0.05* a 4.9%
Endometrial polyp 110 (64%) 42 (57.5%) p>0.05* b 62.1%
Fibroid 10 (5.8%) 2 (2.7%) p>0.05* a 4.9%
Other benign lesions 3 (1.7%) 2 (2.7%) p>0.05* a 2%
Endometrial hyperplasia 6 (3.5%) 6 (8.2%) p>0.05* a 4.9%
Endometrial carcinoma 5 (2.9%) 12 (16.4%) p=0.03** a 6.9%
No sample 27 (15.7%) 4 (5.5%) p=0.03** a 12.7%
Insufficient for diagnosis 4 (2.3%) – – 1.6%
*p value non-significative, **p value significative
a Fisher exact test
bχ2 test
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standard procedure for evaluating uterine cavity, allowing
not only eye-guided biopsies to suspicious areas but also
operative techniques for benign pathology whenever nec-
essary [5–7].
In our study, we evaluated 245 women submitted to
office hysteroscopy after sonographic diagnosis of endo-
metrial thickening and compared asymptomatic with symp-
tomatic patients (with postmenopausal bleeding) in respect
to hysteroscopic and histopathological findings.
The symptomatic patients were significantly older and,
despite identical global rates of patients under HRT, a
higher number of asymptomatic women were under
tamoxifen therapy (probably reflecting their rigorous breast
cancer follow-up).
Pre-procedure medical preparation depended on operator
option. In our institution, the protocol recommends miso-
prostol preparation in postmenopausal women as a cervical
primer, so only a small group of patients did not administer
misoprostol (less than 8%). Cervical local anesthesia was
also preformed in a minority of both groups’ patients
(depending on operator’s option).
The most frequent hysteroscopic and histopathological
diagnosis was endometrial polyp in both groups (69.8%
and 65.7%). See and treat in one session was achieved for
the majority of benign endometrial polyps and fibroids, as
operative office hysteroscopy was feasible, mainly due to
bipolar Versapoint® device utilization.
There is evidence that all intrauterine polypoid lesions of
symptomatic postmenopausal women should be removed
completely. Endometrial cancer may be confused with
benign polyp during hysteroscopy, so one cannot be sure
of polyp diagnosis until it is totally removed [6, 10]. In our
study, 5.4% of apparently benign polyps on hysteroscopy
effectively had focal hyperplasia on pathology and 0.6%
had focal carcinoma. Endometrial hyperplasia, especially
atypical hyperplasia (a well-known risk factor for endome-
trial cancer) occurred in apparently benign polyps of both
symptomatic and asymptomatic women. This aspect high-
lights the importance of total polyp excision after its
diagnosis, even in asymptomatic patients. Additionally,
endometrial polyp malignant degeneration is always a
possibility to consider, occurring in 0.5% to 4.8% of the
cases [6].
Loizzi et al. [10] reported a rate of 28% of hysteroscopic
endometrial pathology in a group of 129 asymptomatic
women with endometrium thickness superior to 4 mm. In
our study, asymptomatic patients had a higher pathology
rate, 77.9%, perhaps reflecting the higher mean patients’
age and the better sonographic accuracy of new equipment.
Also, Schmidt et al. [11], in a recently published article,
found that in 79.3% of 241 patients with asymptomatic
endometrial thickness (more than 6 mm) an endometrial
polyp was present and that in these patients the endometrial
thickness was significantly higher (12±7.4 mm). We did
not evaluate the hysteroscopic/histological data regarding
the value of sonographic endometrial thickness but consid-
ering a different cut-off for asymptomatic women is a
subject of debate.
Global endometrial carcinoma rate in our population
(254 women with endometrial thickening) was 6.9% (17
cases) but as expected symptomatic women had a signif-
icantly higher incidence of carcinoma (16.4% versus 2.9%).
Ribeiro et al. [12] reported only one carcinoma (0.25%) in
399 asymptomatic patients who underwent hysteroscopy
and questioned the utility of ultrasound among asymptom-
atic women. Our experience, on the other hand, favors
sonographic screening in these women since we found
higher rates of carcinoma and endometrial hyperplasia
(2.9% and 3.5%, respectively). A significantly higher
number of asymptomatic patients were under tamoxifen
therapy in our study but all hyperplasia cases appeared in
non-medicated women.
Hysteroscopy had a high specificity and negative
predictive value for diagnosing carcinoma and benign
polyps, with identical values described in literature [13,
14]. Only one case of carcinoma was misdiagnosed in a
polyp with focal carcinoma. Regarding endometrial hyper-
plasia, we had worst results. The three suspected cases were
not confirmed and 12 cases occurred without hysteroscopic
suspicion. Several studies evaluated the accuracy of
hysteroscopy in the diagnosis of endometrial hyperplasia
[14–19] and all of them emphasize the lack of precise
hysteroscopic criteria for hyperplasia diagnosis. In fact, our
results probably underline this aspect. Pathologic exclusion
of hyperplasia should be performed in all cases of thick or
irregular endometrium with guided biopsy.
Table 6 Hysteroscopy duration and associated pain in asymptomatic (group A) and symptomatic (group B) patients
Group A (n=172) Group B (n=73) Statistical significance
Mean procedure duration 31.5±14.7 SD [CI 29.1–33.9] 36.1±15.7 SD [CI 32.2–40] p=0.028** a
Median pain (scale 1–10) 4.0 4.0 p>0.05* b
*p value non-significative, **p value significative
aMann–Whitney U test
b Kruskal–Wallis test
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Symptomatic patients had significantly longer mean
procedure duration, despite identical rates of operative
hysteroscopy, namely operative polypectomy. This aspect
can be related to additional technical difficulties in older
patients in group A or to dimension of the lesions (aspect
not included in the study). On the other hand, this
difference on procedure duration was not reflected on
subjective pain evaluation, since the median value was
identical in both groups. The majority of patients consid-
ered the procedure discomfort tolerable (median 4, in
maximum of 10).
Conclusions
Endometrial thickening associated with postmenopausal
metrorrhagia gives patients a higher risk for endometrial
neoplasia and hyperplasia, compared with asymptomatic
patients. Current hysteroscopic technology allows a rapid,
safe, tolerable, and effective ambulatory technique which
offers the opportunity for the diagnosis and, nearly
always, treatment of endometrial benign pathology after
menopause.
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